<button id="eiezk"><video id="eiezk"></video></button>

產(chǎn)品名稱

Atorvastatin calcium - Lipitor

產(chǎn)品貨號(hào)

Axon 2043 CAS [134523-03-8] MF C33H34FN2O5.?CaMW 577.67 Purity: 99% Soluble in DMSO Description An inhibitor of HMG-CoA reductase (statin) indicated as an adjunct therapy to diet to lower the LDL ("bad") cholesterol and triglycerides in your blood. It can raise your HDL ("good") cholesterol as well. References Certificates Categories Extra info BD Roth. The Discovery and Development of Atorvastatin, a Potent Novel Hypolipidemic Agent. Prog. Med. Chem. 2002, 40, 1–22.? ? S Youssef et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 2002, 420, 78-84.? ? HM Colhoun et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet, 2004, 364 (9435), 685 - 696.? ? PS Sever et al. Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac (...). Drugs 2004, 64 (2 Suppl.), 43-60.? ? JC LaRosa et al. Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease. N. Engl. J. Med. 2005, 352, 1425-1435.? Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology Diabetes & Metabolism HMG-CoA reductase EC 1.1.1.88 Pfizer Licensed Products Inhibitor of HMG-CoA reductase Chemical name (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate hemi-calcium salt Source information Pfizer compound; Sold for research purposes under agreement from Pfizer Inc. Parent CAS No. [134523-00-5] Order Size Unit Price Stock 10 mg €70.00 In Stock

產(chǎn)品價(jià)格

現(xiàn)貨詢價(jià)，電話：010-67529703

產(chǎn)品規(guī)格

產(chǎn)品品牌

axonmedchem

產(chǎn)品概述

產(chǎn)品詳情

Atorvastatin calcium - Lipitor

Based on 16 reference(s) in Google Scholar 9 10 16

Axon 2043

CAS [134523-03-8]

MF C33H34FN2O5.?Ca
MW 577.67

Purity: 99%
Soluble in DMSO

Atorvastatin calcium

Description

An inhibitor of HMG-CoA reductase (statin) indicated as an adjunct therapy to diet to lower the LDL ("bad") cholesterol and triglycerides in your blood. It can raise your HDL ("good") cholesterol as well.

BD Roth. The Discovery and Development of Atorvastatin, a Potent Novel Hypolipidemic Agent. Prog. Med. Chem. 2002, 40, 1–22.?

S Youssef et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 2002, 420, 78-84.?

HM Colhoun et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet, 2004, 364 (9435), 685 - 696.?

PS Sever et al. Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac (...). Drugs 2004, 64 (2 Suppl.), 43-60.?

JC LaRosa et al. Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease. N. Engl. J. Med. 2005, 352, 1425-1435.?

Certificate of Analysis
Material Safety Data Sheet

Cell Signaling & Oncology Diabetes & Metabolism HMG-CoA reductase EC 1.1.1.88 Pfizer Licensed Products

Inhibitor of HMG-CoA reductase

Chemical name

(3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate hemi-calcium salt

Source information

Pfizer compound; Sold for research purposes under agreement from Pfizer Inc.

Parent CAS No.

[134523-00-5]

產(chǎn)品資料

<button id="eiezk"><video id="eiezk"></video></button>